Théa Open Innovation (TOI) is the external innovation unit of Laboratoires Théa, a family-owned, independent company fully dedicated to ophthalmology, operating in 75 countries including North America. Its mission is to identify and support the most promising developments in eye care, regardless of technology, mainly through licensing agreements.

TOI provides:
– Funding to reach human proof of concept
– Deep expertise in clinical development, regulatory approval, market access, and commercialization
– A collaborative model where partners retain full control of their project

TOI is actively seeking collaborations with startups, investors, incubators, and academic teams working in the ophthalmology field. Its focus is on projects that have a lead asset or prototype and early efficacy data (e.g., proof of concept in animal models), and are looking for an industrial partner to accelerate their development.